aminosalicylic acid has been researched along with cholestyramine resin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caspary, WF | 1 |
| Levy, RI | 1 |
| Brown, DD; Juhl, RP; Warner, SL | 2 |
| Azarnoff, DL; Saunders, RN | 1 |
3 review(s) available for aminosalicylic acid and cholestyramine resin
| Article | Year |
|---|---|
[Effect and side effects of drugs on digestive and resorptive function of small intestine].
Topics: Aminosalicylic Acid; Biguanides; Bile Acids and Salts; Cardiac Glycosides; Cathartics; Cholestyramine Resin; Harmaline; Humans; Intestine, Small; Malabsorption Syndromes; Neomycin; Oligomycins; Phenytoin; Phlorhizin; Prenylamine | 1977 |
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols | 1977 |
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
1 trial(s) available for aminosalicylic acid and cholestyramine resin
| Article | Year |
|---|---|
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
2 other study(ies) available for aminosalicylic acid and cholestyramine resin
| Article | Year |
|---|---|
Effects of hypocholesterolemic interventions on digoxin bioavailability.
Topics: Aminosalicylic Acid; Anticholesteremic Agents; Biological Availability; Cholestyramine Resin; Diet; Dietary Fiber; Digoxin; Drug Interactions; Humans; Intestinal Absorption; Time Factors | 1979 |
Decreased bioavailability of digoxin due to hypocholesterolemic interventions.
Topics: Adsorption; Adult; Aminosalicylic Acid; Anticholesteremic Agents; Biological Availability; Cholestyramine Resin; Dietary Fiber; Digoxin; Drug Interactions; Humans; Time Factors | 1978 |